ABSTRACT Earlier reports on the detection of Helicobacter DNA in the gallbladder tissue of patients with biliary diseases have shown discordant results. This study aimed to detect the presence of Helicobacter in gallstone, gallbladder tissue and bile specimens from subjects with H. pylori-positive gastritis with cholelithiasis. The presence of H. pylori in antrum biopsies was confirmed by rapid urease test and/or histopathological examination. DNA was extracted from gallbladder, bile and gallstone samples from 50 patients undergoing cholecystectomy. The presence of Helicobacter genus-specific DNA (16S rRNA genes) was determined by nested polymerase chain reaction assay. Helicobacter DNA was detected in the gallbladder tissue and bile of 28% and 18% respectively of the patients, but was not detected in any of the gallstones. These results do not rule out the possibility of Helicobacter infection as a contributing agent or cofactor in the development of biliary diseases. 
Introduction
The rediscovery of the bacterium in the stomach by histological examination of gastric biopsies and its first isolation by Warren and Marshall in 1983 led to new approaches to the management of various gastroduodenal disorders [1] . Its relevance to human disease, specifically to peptic ulcer disease, gastritis and gastric malignancy, is indisputable [2] . H. pylori infection has also now been implicated as a risk factor for various extraintestinal diseases and Helicobacter species have been suggested as a cause of hepatobiliary diseases in some animals [3] . Figura et al. proposed that H. pylori present in human bile samples might represent a risk factor for gallstone formation [4] . These reports stimulated interest as to whether these organisms colonize the biliary tract of humans and cause hepatobiliary diseases. The evidence, however, concerning the presence of Helicobacter DNA in the bile and biliary tissue of human beings with biliary diseases is controversial [5] [6] [7] [8] . In some studies, the presence of intestinal Helicobacter spp. or H. pylori DNA was detected in bile and or gallbladder tissue from patients with benign or malignant biliary diseases [9] . In contrast, other authors did not detect any Helicobacter DNA in the biliary trees of patients with the same diseases [10] . The role of Helicobacter in the pathogenesis of gallbladder disease in humans, or even its presence in gallbladder tissue, therefore remains unclear. The objective of this study was to investigate the presence of Helicobacter in the gallbladder, bile and gallstones of a group of Egyptian patients with H. pylori-positive gastritis with cholelithiasis who had undergone cholecystectomy.
Methods

Patients
A total of 50 patients with gallbladder stones admitted to University of Alexandria main hospital for cholecystectomy during the period November 2008 to June 2010 were included in this study. All patients were off any antiulcer therapy and antimicrobial drugs for at least 2 weeks before enrolment in the study. Patients with chronic pancreatitis, inflammatory bowel disease, liver cirrhosis, underlying malignancy or familial hypercholesterolaemia were excluded from the study. The study was approved by the ethics committee of each institution, and informed consent was obtained from all patients.
Data collection
Clinical studies All patients received diagnostic upper gastrointestinal endoscopy and gastric biopsies were taken to confirm the bacterial etiology of the gastritis. Two biopsies were taken from the antrum to detect H. pylori, one for the rapid urease test [11] and the other for histopathological examination. Biopsies for histology were immediately fixed in 10% buffered formalin. The samples were then embedded in paraffin wax and histological sections were stained with haematoxylin and eosin for histological analysis.
Molecular studies
Gallbladder tissue specimens, gallstone and bile samples were obtained from each patient after cholecystectomy. The samples were immediately frozen at -20 °C for DNA extraction.
Extraction from gallstones [12] : DNA was extracted with a QIAamp DNA mini kit (Qiagen) according to the manufacturer's recommendations, with minor modifications. After washing with phosphate-buffered saline, each gallstone was cut into small pieces by scraping into a clean culture dish. Then 25-30 mg was put in 1.5 mL Eppendorf tubes and 200 mL sterile digestive buffer [20 mM Tris-HCl, EDTA-Na 2 (pH 8.0), 2 mM; 1.2% Triton X100], was added to each tube. The content of the tubes was homogenized using a sterile plastic syringe, then 7 µL lysozyme (50 mg/mL) was added to each tube and incubated at 37 ºC for 1 h, this was followed by the addition of 200 µL of ATL buffer and 20 µL proteinase K (20 mg/mL) and incubated at 56 ºC overnight. To each sample, 200 µL of AL buffer were added and the samples were centrifuged at 8000 rpm for 10 min. The supernatant was transferred to a new sterile Eppendorf tube and the pellets were resuspended in 100 µL of AL buffer, vortexed and centrifuged as before. The combined supernatants were incubated at 70 ºC for 10 min then 300 µL ethanol were added and the samples was applied to the QIAamp spin column in a 2 mL collection tube were processed according to Qiagen protocol. Finally, the DNA was eluted with 50 µL of AE buffer.
Extraction from gallbladder tissue or bile [13] : 25 mg samples of gallbladder mucosa were washed with phosphate-buffered saline and 500 µL samples of refrigerated bile were pelleted by centrifugation for 10 minutes at 14 000 rpm. Gallbladder tissue or bile sediments were then suspended in 180 µL of lysis buffer (ATL buffer) and homogenized by vortexing, and the samples were processed according to Qiagen protocol but the column material was washed twice (250 µL each time) with the first buffer (AW1 buffer) and twice (250 µL each time) with the second washing buffer (AW2 buffer) provided in the kit.
B-PCR amplification B-PCR amplification was done using
Helicobacter genus-specific primers [13] . The 16S rRNA gene of the genus Helicobacter was amplified by a nested polymerase chain reaction (PCR) assay. The outer primer pair (B37 and C70) was used to generate 16S rRNA amplicons of approximately 1500 bp. The nested inner primer pairs, which are specific for the Helicobacter genus, amplified fragments of 400 bp (primer pair C97 and C98). Table 1 shows the nucleotide sequences of the 4 primers, the PCR conditions, and the size of the amplified fragments. Ten µL of eluted DNA was used with the outer primer (C70/B37) in the first amplification. In the second round, 5 µL of the PCR product was added to the reaction mixture using the nested inner primer pairs (C97/C98). PCRs were performed in a total volume of 50 µL using 2 × PCR master mix (Qiagen) containing 0.05 units/mL of Taq DNA polymerase, PCR buffer, 2 mM MgCl 2 , 0.2 mM of dNTPs, with 50 pmole of each primer. A negative control was included in the reaction using sterile distilled water instead of DNA to exclude the possibility of contamination. PCR products were analysed by electrophoresis using 1.5% (w/v) agarose gel stained with ethidium bromide. The sizes of the PCR products were estimated by comparison with 100 bp DNA size markers (Fermentas).
Results
A total of 50 patients diagnosed with gastritis presenting with gallbladder stones to the Alexandria University hospital were enrolled in this study. They were 36 females (72%) and 14 (28%) males with ages ranging from 24-68 years, mean age 42.6 (SD 12.6) years.
Histological examination of antrum tissue specimens showed that 42 (84%) were positive for H. pylori, while the rapid urease test gave positive results in 34 (68%) of cases ( Table 2 ). H. pylori was confirmed by both tests in 26 (52%) cases. However, the urease test was negative in 16 (32%) cases that were histologically positive for H. pylori and the urease test was positive in 8 (16%) cases that were histologically negative for H. pylori.
Helicobacter DNA was detected by nested PCR in the gallbladder tissue and bile from 14 (28%) and 9 (18%) patients respectively (Table 3 and Figure 1 ). PCR was positive in both gallbladder tissue and bile in 6 (12%) patients, while PCR was positive in gallbladder tissue only in 8 (6%) cases and was only positive in bile in 3 (6%) cases. No gallstones (0%) were positive for Helicobacter DNA by nested PCR.
Discussion
The presence of Helicobacter spp./H. pylori DNA in the gallbladder epithelium of patients with cholelithiasis and cholecystitis has been addressed by several investigators. However, the results are conflicting and some investigators have detected the presence of H. pylori DNA [13] while others have not [8, 14] . Accordingly, whether H. pylori participates in the pathogenesis of biliary diseases is a question that remains unresolved. For this reason, the presence of Helicobacter DNA in gallbladder tissue, gallstone and bile from 50 patients with cholelithiasis who had undergone cholecystectomy was investigated by nested-PCR assay using the 16S rRNA gene of the genus Helicobacter.
In this study, Helicobacter DNA was detected in the gallbladder mucosa in 28% of patients with cholelithiasis. This figure agrees with 2 other studies identifying DNA of Helicobacter spp. in 22%-27.7% of gallbladder samples [15, 16] . While Silva et al. detected Helicobacter DNA in gallbladder tissue in 31.3% of their cases, they pointed out the possibility that H. pylori had Table 1 colonized a previously damaged epithelium [13] . In contrast, our rate was much lower than that of Apostolov et al., who reported positive H. pylori DNA in the gallbladder tissue of 73% of Ukrainian patients with cholecystitis [17] , and it was much higher than Méndez-Sánchez et al., who found a very low incidence (3%) of Helicobacter colonization in the gallbladder epithelium of a Mexican population (detected using Helicobacter-specific 16S rRNA primers) [8] . Méndez-Sánchez et al.
argued that the existence of uncommon Helicobacter spp in gallbladder epithelium and its association with gallstone pathogenesis could not be discarded. Moreover, in our study, Helicobacter DNA could be detected in the bile of 18% of patients presenting with gallbladder stones. Similar data was reported by Lee et al., who found Helicobacter DNA in 25% of the bile from patients with gallstones [15] . Still higher rates (42.9% and 96.7%) were reported in the bile of patients diagnosed with various hepatobiliary diseases by other authors [1, 13] . Fox et al. reported that bile samples from 56.5% of 23 Chilean patients with chronic cholecystitis were positive for Helicobacter spp [7] . These were analysed by DNA sequencing and were found to be bile-resistant hepatic Helicobacter spp. (H. bilis, H. pullorum and Flexispira rappini), known to be closely associated with gallbladder cancer. Intestinal Helicobacter spp. are bile-resistant, a property that may confer protection against the deleterious effects of bile in vivo and allow them to adapt better to the hepatobiliary surroundings [13] .
In this study, the presence of Helicobacter spp. DNA in gallbladder tissue or bile could be linked with the presence of H. pylori in the antrum. Chen et al. reported that Helicobacter spp. DNA are commonly present in the gallbladder of patients with gallstone diseases and in controls, implying that Helicobacter infection alone may not play a significant role in the formation of gallstones [18] . However their results did not exclude the possibility of Helicobacter infection as a cofactor in the development of gallstones. Also, in a German study no Helicobacter spp. were found in bile samples, suggesting that there may be racial and demographic differences in the etiology of gallstones [14] .
It has been proposed that the presence of H. pylori in bile may represent an increased risk of gallstone formation [4] . A possible consequence of colonization by Helicobacter spp. is a chronic inflammation in the gallbladder mucosa. This inflammation may impair gallbladder mucosa acid secretion and acidification of the contents [19] , reducing the solubility of calcium salts in gallbladder bile and increasing the risk of their precipitation in the lumen [20] . Helicobacter spp. were assessed by PCR in gallstones in several studies. In a study from Sweden, Monstein et al. detected H. pylori in 55% of cholesterol gallstones, in addition to other bacteria [12] . In our study, Helicobacter could not be detected by PCR in any gallstones. However Farshad et al. reported the presence of H. pylori DNA in 18.1% of stone samples and suggested that H. pylori infection may serve as an initiating factor or play other important roles in the development of gallstones [21] .
The reasons for observed discrepancies in the detection rate of Helicobacter among different studies are currently unclear, but differences in PCR sensitivities between laboratories and geographical variations in human exposure to H. pylori are 2 possible explanations. These differences reflect the need for prospective studies using accurate tests designed to clarify the clinical role of Helicobacter spp. in gallbladder disease. Also, the small number of patients enrolled in all these studies, including ours, may be a factor. Therefore larger patient and control groups are needed to ascertain whether this microorganism is an innocent bystander or active participant in gallstone formation.
In conclusion, the results of the present study revealed the presence of Helicobacter DNA in gallbladder tissue and bile from patients with gallbladder diseases. Further studies are needed to determine whether Helicobacter spp. is a causative agent of biliary diseases or a cofactor. 
